ATEX three-lens brief
Evidence-based stock research on ATEX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 10.0pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 10.0pp over 30 days.
- Analyst mean target $112.33 — 36% above current (3 analysts).
- Negative free cash flow last quarterly (-$71.30M).
ATEX closed at $82.79 (-1.36%) as of 2026-09-11. Market cap: $1.62B. P/E (trailing) 24.1. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $112.33 — 36% above current (3 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 10.0pp over 30 days.. Last quarter: Revenue $1.96M, net income $240.0K, free cash flow -$71.30M.
Why three lenses on ATEX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ATEXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ATEX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ATEX brief"></iframe>